Dow Chemical announced plans to build and operate a pilot-scale algae-based integrated biorefinery with algenol biofuels. The company plans to develop the advanced materials and specialty films for the photobioreactor system. The facility is planned to be located at Dow's Freeport, Texas, U.S. site.
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.
The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.
Digital processes in hazardous areas? Durabook's rugged tablets are ATEX-certified for industrial use.
